Glottic Cancer Treatment Market, Global Outlook and Forecast 2022-2028

March 2022 | 61 pages | ID: G2865CA416F2EN
Market Monitor Global

Abstracts

Cancer that forms in tissues of the larynx in the glottis or vocal cords are called as glottic cancer.

This report contains market size and forecasts of Glottic Cancer Treatment in Global, including the following market information:

Global Glottic Cancer Treatment Market Revenue, 2017-2022, 2023-2028, ($ millions)

Global top five companies in 2021 (%)

The global Glottic Cancer Treatment market was valued at million in 2021 and is projected to reach US$ million by 2028, at a CAGR of % during the forecast period.

The U.S. Market is Estimated at $ Million in 2021, While China is Forecast to Reach $ Million by 2028.

Surgical Treatment Segment to Reach $ Million by 2028, with a % CAGR in next six years.

The global key manufacturers of Glottic Cancer Treatment include Novartis, Eli Lilly, Cipla, Amgen, Biocon, Bristol-Myers Squibb, Merck, Pfizer and Celgene, etc. In 2021, the global top five players have a share approximately % in terms of revenue.

MARKET MONITOR GLOBAL, INC (MMG) has surveyed the Glottic Cancer Treatment companies, and industry experts on this industry, involving the revenue, demand, product type, recent developments and plans, industry trends, drivers, challenges, obstacles, and potential risks.

Total Market by Segment:

Global Glottic Cancer Treatment Market, by Type, 2017-2022, 2023-2028 ($ millions)

Global Glottic Cancer Treatment Market Segment Percentages, by Type, 2021 (%)

• Surgical Treatment
• Drug Treatment

Global Glottic Cancer Treatment Market, by Application, 2017-2022, 2023-2028 ($ millions)

Global Glottic Cancer Treatment Market Segment Percentages, by Application, 2021 (%)

• Hospital
• Clinic
• Ambulatory Surgical Center
• Others

Global Glottic Cancer Treatment Market, By Region and Country, 2017-2022, 2023-2028 ($ Millions)

Global Glottic Cancer Treatment Market Segment Percentages, By Region and Country, 2021 (%)

• North America
• US
• Canada
• Mexico
• Europe
• Germany
• France
• U.K.
• Italy
• Russia
• Nordic Countries
• Benelux
• Rest of Europe
• Asia
• China
• Japan
• South Korea
• Southeast Asia
• India
• Rest of Asia
• South America
• Brazil
• Argentina
• Rest of South America
• Middle East & Africa
• Turkey
• Israel
• Saudi Arabia
• UAE
• Rest of Middle East & Africa

Competitor Analysis

The report also provides analysis of leading market participants including:

Key companies Glottic Cancer Treatment revenues in global market, 2017-2022 (estimated), ($ millions)

Key companies Glottic Cancer Treatment revenues share in global market, 2021 (%)

Further, the report presents profiles of competitors in the market, key players include:

• Novartis
• Eli Lilly
• Cipla
• Amgen
• Biocon
• Bristol-Myers Squibb
• Merck
• Pfizer
• Celgene
• Roche
• Teva

Contents

1 INTRODUCTION TO RESEARCH & ANALYSIS REPORTS

1.1 Glottic Cancer Treatment Market Definition
1.2 Market Segments
  1.2.1 Market by Type
  1.2.2 Market by Application
1.3 Global Glottic Cancer Treatment Market Overview
1.4 Features & Benefits of This Report
1.5 Methodology & Sources of Information
  1.5.1 Research Methodology
  1.5.2 Research Process
  1.5.3 Base Year
  1.5.4 Report Assumptions & Caveats

2 GLOBAL GLOTTIC CANCER TREATMENT OVERALL MARKET SIZE

2.1 Global Glottic Cancer Treatment Market Size: 2021 VS 2028
2.2 Global Glottic Cancer Treatment Market Size, Prospects & Forecasts: 2017-2028
2.3 Key Market Trends, Opportunity, Drivers and Restraints
  2.3.1 Market Opportunities & Trends
  2.3.2 Market Drivers
  2.3.3 Market Restraints

3 COMPANY LANDSCAPE

3.1 Top Glottic Cancer Treatment Players in Global Market
3.2 Top Global Glottic Cancer Treatment Companies Ranked by Revenue
3.3 Global Glottic Cancer Treatment Revenue by Companies
3.4 Top 3 and Top 5 Glottic Cancer Treatment Companies in Global Market, by Revenue in 2021
3.5 Global Companies Glottic Cancer Treatment Product Type
3.6 Tier 1, Tier 2 and Tier 3 Glottic Cancer Treatment Players in Global Market
  3.6.1 List of Global Tier 1 Glottic Cancer Treatment Companies
  3.6.2 List of Global Tier 2 and Tier 3 Glottic Cancer Treatment Companies

4 MARKET SIGHTS BY PRODUCT

4.1 Overview
  4.1.1 by Type - Global Glottic Cancer Treatment Market Size Markets, 2021 & 2028
  4.1.2 Surgical Treatment
  4.1.3 Drug Treatment
4.2 By Type - Global Glottic Cancer Treatment Revenue & Forecasts
  4.2.1 By Type - Global Glottic Cancer Treatment Revenue, 2017-2022
  4.2.2 By Type - Global Glottic Cancer Treatment Revenue, 2023-2028
  4.2.3 By Type - Global Glottic Cancer Treatment Revenue Market Share, 2017-2028

5 SIGHTS BY APPLICATION

5.1 Overview
  5.1.1 By Application - Global Glottic Cancer Treatment Market Size, 2021 & 2028
  5.1.2 Hospital
  5.1.3 Clinic
  5.1.4 Ambulatory Surgical Center
  5.1.5 Others
5.2 By Application - Global Glottic Cancer Treatment Revenue & Forecasts
  5.2.1 By Application - Global Glottic Cancer Treatment Revenue, 2017-2022
  5.2.2 By Application - Global Glottic Cancer Treatment Revenue, 2023-2028
  5.2.3 By Application - Global Glottic Cancer Treatment Revenue Market Share, 2017-2028

6 SIGHTS BY REGION

6.1 By Region - Global Glottic Cancer Treatment Market Size, 2021 & 2028
6.2 By Region - Global Glottic Cancer Treatment Revenue & Forecasts
  6.2.1 By Region - Global Glottic Cancer Treatment Revenue, 2017-2022
  6.2.2 By Region - Global Glottic Cancer Treatment Revenue, 2023-2028
  6.2.3 By Region - Global Glottic Cancer Treatment Revenue Market Share, 2017-2028
6.3 North America
  6.3.1 By Country - North America Glottic Cancer Treatment Revenue, 2017-2028
  6.3.2 US Glottic Cancer Treatment Market Size, 2017-2028
  6.3.3 Canada Glottic Cancer Treatment Market Size, 2017-2028
  6.3.4 Mexico Glottic Cancer Treatment Market Size, 2017-2028
6.4 Europe
  6.4.1 By Country - Europe Glottic Cancer Treatment Revenue, 2017-2028
  6.4.2 Germany Glottic Cancer Treatment Market Size, 2017-2028
  6.4.3 France Glottic Cancer Treatment Market Size, 2017-2028
  6.4.4 U.K. Glottic Cancer Treatment Market Size, 2017-2028
  6.4.5 Italy Glottic Cancer Treatment Market Size, 2017-2028
  6.4.6 Russia Glottic Cancer Treatment Market Size, 2017-2028
  6.4.7 Nordic Countries Glottic Cancer Treatment Market Size, 2017-2028
  6.4.8 Benelux Glottic Cancer Treatment Market Size, 2017-2028
6.5 Asia
  6.5.1 By Region - Asia Glottic Cancer Treatment Revenue, 2017-2028
  6.5.2 China Glottic Cancer Treatment Market Size, 2017-2028
  6.5.3 Japan Glottic Cancer Treatment Market Size, 2017-2028
  6.5.4 South Korea Glottic Cancer Treatment Market Size, 2017-2028
  6.5.5 Southeast Asia Glottic Cancer Treatment Market Size, 2017-2028
  6.5.6 India Glottic Cancer Treatment Market Size, 2017-2028
6.6 South America
  6.6.1 By Country - South America Glottic Cancer Treatment Revenue, 2017-2028
  6.6.2 Brazil Glottic Cancer Treatment Market Size, 2017-2028
  6.6.3 Argentina Glottic Cancer Treatment Market Size, 2017-2028
6.7 Middle East & Africa
  6.7.1 By Country - Middle East & Africa Glottic Cancer Treatment Revenue, 2017-2028
  6.7.2 Turkey Glottic Cancer Treatment Market Size, 2017-2028
  6.7.3 Israel Glottic Cancer Treatment Market Size, 2017-2028
  6.7.4 Saudi Arabia Glottic Cancer Treatment Market Size, 2017-2028
  6.7.5 UAE Glottic Cancer Treatment Market Size, 2017-2028

7 PLAYERS PROFILES

7.1 Novartis
  7.1.1 Novartis Corporate Summary
  7.1.2 Novartis Business Overview
  7.1.3 Novartis Glottic Cancer Treatment Major Product Offerings
  7.1.4 Novartis Glottic Cancer Treatment Revenue in Global Market (2017-2022)
  7.1.5 Novartis Key News
7.2 Eli Lilly
  7.2.1 Eli Lilly Corporate Summary
  7.2.2 Eli Lilly Business Overview
  7.2.3 Eli Lilly Glottic Cancer Treatment Major Product Offerings
  7.2.4 Eli Lilly Glottic Cancer Treatment Revenue in Global Market (2017-2022)
  7.2.5 Eli Lilly Key News
7.3 Cipla
  7.3.1 Cipla Corporate Summary
  7.3.2 Cipla Business Overview
  7.3.3 Cipla Glottic Cancer Treatment Major Product Offerings
  7.3.4 Cipla Glottic Cancer Treatment Revenue in Global Market (2017-2022)
  7.3.5 Cipla Key News
7.4 Amgen
  7.4.1 Amgen Corporate Summary
  7.4.2 Amgen Business Overview
  7.4.3 Amgen Glottic Cancer Treatment Major Product Offerings
  7.4.4 Amgen Glottic Cancer Treatment Revenue in Global Market (2017-2022)
  7.4.5 Amgen Key News
7.5 Biocon
  7.5.1 Biocon Corporate Summary
  7.5.2 Biocon Business Overview
  7.5.3 Biocon Glottic Cancer Treatment Major Product Offerings
  7.5.4 Biocon Glottic Cancer Treatment Revenue in Global Market (2017-2022)
  7.5.5 Biocon Key News
7.6 Bristol-Myers Squibb
  7.6.1 Bristol-Myers Squibb Corporate Summary
  7.6.2 Bristol-Myers Squibb Business Overview
  7.6.3 Bristol-Myers Squibb Glottic Cancer Treatment Major Product Offerings
  7.6.4 Bristol-Myers Squibb Glottic Cancer Treatment Revenue in Global Market (2017-2022)
  7.6.5 Bristol-Myers Squibb Key News
7.7 Merck
  7.7.1 Merck Corporate Summary
  7.7.2 Merck Business Overview
  7.7.3 Merck Glottic Cancer Treatment Major Product Offerings
  7.7.4 Merck Glottic Cancer Treatment Revenue in Global Market (2017-2022)
  7.7.5 Merck Key News
7.8 Pfizer
  7.8.1 Pfizer Corporate Summary
  7.8.2 Pfizer Business Overview
  7.8.3 Pfizer Glottic Cancer Treatment Major Product Offerings
  7.8.4 Pfizer Glottic Cancer Treatment Revenue in Global Market (2017-2022)
  7.8.5 Pfizer Key News
7.9 Celgene
  7.9.1 Celgene Corporate Summary
  7.9.2 Celgene Business Overview
  7.9.3 Celgene Glottic Cancer Treatment Major Product Offerings
  7.9.4 Celgene Glottic Cancer Treatment Revenue in Global Market (2017-2022)
  7.9.5 Celgene Key News
7.10 Roche
  7.10.1 Roche Corporate Summary
  7.10.2 Roche Business Overview
  7.10.3 Roche Glottic Cancer Treatment Major Product Offerings
  7.10.4 Roche Glottic Cancer Treatment Revenue in Global Market (2017-2022)
  7.10.5 Roche Key News
7.11 Teva
  7.11.1 Teva Corporate Summary
  7.11.2 Teva Business Overview
  7.11.3 Teva Glottic Cancer Treatment Major Product Offerings
  7.11.4 Teva Glottic Cancer Treatment Revenue in Global Market (2017-2022)
  7.11.5 Teva Key News

8 CONCLUSION

9 APPENDIX

9.1 Note
9.2 Examples of Clients
9.3 Disclaimer

List Of Tables

LIST OF TABLES

Table 1. Glottic Cancer Treatment Market Opportunities & Trends in Global Market
Table 2. Glottic Cancer Treatment Market Drivers in Global Market
Table 3. Glottic Cancer Treatment Market Restraints in Global Market
Table 4. Key Players of Glottic Cancer Treatment in Global Market
Table 5. Top Glottic Cancer Treatment Players in Global Market, Ranking by Revenue (2021)
Table 6. Global Glottic Cancer Treatment Revenue by Companies, (US$, Mn), 2017-2022
Table 7. Global Glottic Cancer Treatment Revenue Share by Companies, 2017-2022
Table 8. Global Companies Glottic Cancer Treatment Product Type
Table 9. List of Global Tier 1 Glottic Cancer Treatment Companies, Revenue (US$, Mn) in 2021 and Market Share
Table 10. List of Global Tier 2 and Tier 3 Glottic Cancer Treatment Companies, Revenue (US$, Mn) in 2021 and Market Share
Table 11. By Type – Global Glottic Cancer Treatment Revenue, (US$, Mn), 2021 & 2028
Table 12. By Type - Glottic Cancer Treatment Revenue in Global (US$, Mn), 2017-2022
Table 13. By Type - Glottic Cancer Treatment Revenue in Global (US$, Mn), 2023-2028
Table 14. By Application – Global Glottic Cancer Treatment Revenue, (US$, Mn), 2021 & 2028
Table 15. By Application - Glottic Cancer Treatment Revenue in Global (US$, Mn), 2017-2022
Table 16. By Application - Glottic Cancer Treatment Revenue in Global (US$, Mn), 2023-2028
Table 17. By Region – Global Glottic Cancer Treatment Revenue, (US$, Mn), 2021 & 2028
Table 18. By Region - Global Glottic Cancer Treatment Revenue (US$, Mn), 2017-2022
Table 19. By Region - Global Glottic Cancer Treatment Revenue (US$, Mn), 2023-2028
Table 20. By Country - North America Glottic Cancer Treatment Revenue, (US$, Mn), 2017-2022
Table 21. By Country - North America Glottic Cancer Treatment Revenue, (US$, Mn), 2023-2028
Table 22. By Country - Europe Glottic Cancer Treatment Revenue, (US$, Mn), 2017-2022
Table 23. By Country - Europe Glottic Cancer Treatment Revenue, (US$, Mn), 2023-2028
Table 24. By Region - Asia Glottic Cancer Treatment Revenue, (US$, Mn), 2017-2022
Table 25. By Region - Asia Glottic Cancer Treatment Revenue, (US$, Mn), 2023-2028
Table 26. By Country - South America Glottic Cancer Treatment Revenue, (US$, Mn), 2017-2022
Table 27. By Country - South America Glottic Cancer Treatment Revenue, (US$, Mn), 2023-2028
Table 28. By Country - Middle East & Africa Glottic Cancer Treatment Revenue, (US$, Mn), 2017-2022
Table 29. By Country - Middle East & Africa Glottic Cancer Treatment Revenue, (US$, Mn), 2023-2028
Table 30. Novartis Corporate Summary
Table 31. Novartis Glottic Cancer Treatment Product Offerings
Table 32. Novartis Glottic Cancer Treatment Revenue (US$, Mn), (2017-2022)
Table 33. Eli Lilly Corporate Summary
Table 34. Eli Lilly Glottic Cancer Treatment Product Offerings
Table 35. Eli Lilly Glottic Cancer Treatment Revenue (US$, Mn), (2017-2022)
Table 36. Cipla Corporate Summary
Table 37. Cipla Glottic Cancer Treatment Product Offerings
Table 38. Cipla Glottic Cancer Treatment Revenue (US$, Mn), (2017-2022)
Table 39. Amgen Corporate Summary
Table 40. Amgen Glottic Cancer Treatment Product Offerings
Table 41. Amgen Glottic Cancer Treatment Revenue (US$, Mn), (2017-2022)
Table 42. Biocon Corporate Summary
Table 43. Biocon Glottic Cancer Treatment Product Offerings
Table 44. Biocon Glottic Cancer Treatment Revenue (US$, Mn), (2017-2022)
Table 45. Bristol-Myers Squibb Corporate Summary
Table 46. Bristol-Myers Squibb Glottic Cancer Treatment Product Offerings
Table 47. Bristol-Myers Squibb Glottic Cancer Treatment Revenue (US$, Mn), (2017-2022)
Table 48. Merck Corporate Summary
Table 49. Merck Glottic Cancer Treatment Product Offerings
Table 50. Merck Glottic Cancer Treatment Revenue (US$, Mn), (2017-2022)
Table 51. Pfizer Corporate Summary
Table 52. Pfizer Glottic Cancer Treatment Product Offerings
Table 53. Pfizer Glottic Cancer Treatment Revenue (US$, Mn), (2017-2022)
Table 54. Celgene Corporate Summary
Table 55. Celgene Glottic Cancer Treatment Product Offerings
Table 56. Celgene Glottic Cancer Treatment Revenue (US$, Mn), (2017-2022)
Table 57. Roche Corporate Summary
Table 58. Roche Glottic Cancer Treatment Product Offerings
Table 59. Roche Glottic Cancer Treatment Revenue (US$, Mn), (2017-2022)
Table 60. Teva Corporate Summary
Table 61. Teva Glottic Cancer Treatment Product Offerings
Table 62. Teva Glottic Cancer Treatment Revenue (US$, Mn), (2017-2022)

List Of Figures

LIST OF FIGURES

Figure 1. Glottic Cancer Treatment Segment by Type in 2021
Figure 2. Glottic Cancer Treatment Segment by Application in 2021
Figure 3. Global Glottic Cancer Treatment Market Overview: 2021
Figure 4. Key Caveats
Figure 5. Global Glottic Cancer Treatment Market Size: 2021 VS 2028 (US$, Mn)
Figure 6. Global Glottic Cancer Treatment Revenue, 2017-2028 (US$, Mn)
Figure 7. The Top 3 and 5 Players Market Share by Glottic Cancer Treatment Revenue in 2021
Figure 8. By Type - Global Glottic Cancer Treatment Revenue Market Share, 2017-2028
Figure 9. By Application - Global Glottic Cancer Treatment Revenue Market Share, 2017-2028
Figure 10. By Region - Global Glottic Cancer Treatment Revenue Market Share, 2017-2028
Figure 11. By Country - North America Glottic Cancer Treatment Revenue Market Share, 2017-2028
Figure 12. US Glottic Cancer Treatment Revenue, (US$, Mn), 2017-2028
Figure 13. Canada Glottic Cancer Treatment Revenue, (US$, Mn), 2017-2028
Figure 14. Mexico Glottic Cancer Treatment Revenue, (US$, Mn), 2017-2028
Figure 15. By Country - Europe Glottic Cancer Treatment Revenue Market Share, 2017-2028
Figure 16. Germany Glottic Cancer Treatment Revenue, (US$, Mn), 2017-2028
Figure 17. France Glottic Cancer Treatment Revenue, (US$, Mn), 2017-2028
Figure 18. U.K. Glottic Cancer Treatment Revenue, (US$, Mn), 2017-2028
Figure 19. Italy Glottic Cancer Treatment Revenue, (US$, Mn), 2017-2028
Figure 20. Russia Glottic Cancer Treatment Revenue, (US$, Mn), 2017-2028
Figure 21. Nordic Countries Glottic Cancer Treatment Revenue, (US$, Mn), 2017-2028
Figure 22. Benelux Glottic Cancer Treatment Revenue, (US$, Mn), 2017-2028
Figure 23. By Region - Asia Glottic Cancer Treatment Revenue Market Share, 2017-2028
Figure 24. China Glottic Cancer Treatment Revenue, (US$, Mn), 2017-2028
Figure 25. Japan Glottic Cancer Treatment Revenue, (US$, Mn), 2017-2028
Figure 26. South Korea Glottic Cancer Treatment Revenue, (US$, Mn), 2017-2028
Figure 27. Southeast Asia Glottic Cancer Treatment Revenue, (US$, Mn), 2017-2028
Figure 28. India Glottic Cancer Treatment Revenue, (US$, Mn), 2017-2028
Figure 29. By Country - South America Glottic Cancer Treatment Revenue Market Share, 2017-2028
Figure 30. Brazil Glottic Cancer Treatment Revenue, (US$, Mn), 2017-2028
Figure 31. Argentina Glottic Cancer Treatment Revenue, (US$, Mn), 2017-2028
Figure 32. By Country - Middle East & Africa Glottic Cancer Treatment Revenue Market Share, 2017-2028
Figure 33. Turkey Glottic Cancer Treatment Revenue, (US$, Mn), 2017-2028
Figure 34. Israel Glottic Cancer Treatment Revenue, (US$, Mn), 2017-2028
Figure 35. Saudi Arabia Glottic Cancer Treatment Revenue, (US$, Mn), 2017-2028
Figure 36. UAE Glottic Cancer Treatment Revenue, (US$, Mn), 2017-2028
Figure 37. Novartis Glottic Cancer Treatment Revenue Year Over Year Growth (US$, Mn) & (2017-2022)
Figure 38. Eli Lilly Glottic Cancer Treatment Revenue Year Over Year Growth (US$, Mn) & (2017-2022)
Figure 39. Cipla Glottic Cancer Treatment Revenue Year Over Year Growth (US$, Mn) & (2017-2022)
Figure 40. Amgen Glottic Cancer Treatment Revenue Year Over Year Growth (US$, Mn) & (2017-2022)
Figure 41. Biocon Glottic Cancer Treatment Revenue Year Over Year Growth (US$, Mn) & (2017-2022)
Figure 42. Bristol-Myers Squibb Glottic Cancer Treatment Revenue Year Over Year Growth (US$, Mn) & (2017-2022)
Figure 43. Merck Glottic Cancer Treatment Revenue Year Over Year Growth (US$, Mn) & (2017-2022)
Figure 44. Pfizer Glottic Cancer Treatment Revenue Year Over Year Growth (US$, Mn) & (2017-2022)
Figure 45. Celgene Glottic Cancer Treatment Revenue Year Over Year Growth (US$, Mn) & (2017-2022)
Figure 46. Roche Glottic Cancer Treatment Revenue Year Over Year Growth (US$, Mn) & (2017-2022)
Figure 47. Teva Glottic Cancer Treatment Revenue Year Over Year Growth (US$, Mn) & (2017-2022)